Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs

被引：0
|
作者：
Ernest Choy
Nick Freemantle
Clare Proudfoot
Chieh-I Chen
Laurence Pollissard
Andreas Kuznik
Hubert van Hoogstraten
Erin Mangan
Paulo Carita
Thi-Minh-Thao Huynh
机构：
[1] Cardiff University,
[2] University College London,undefined
[3] Formerly of Sanofi,undefined
[4] Regeneron Pharmaceuticals,undefined
[5] Inc.,undefined
[6] Sanofi France,undefined
[7] Sanofi,undefined
来源：
Advances in Therapy | 2019年 / 36卷
关键词：
Biologic disease-modifying antirheumatic drugs; Network meta-analysis; Rheumatoid arthritis; Rheumatology; Sarilumab monotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：817 / 827
页数：10
相关论文
共 50 条
  • [41] Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs A Comprehensive Review of Phase 3 Efficacy and Safety
    Bird, Paul
    Bensen, William
    El-Zorkany, Bassel
    Kaine, Jeffrey
    Manapat-Reyes, Bernadette Heizel
    Pascual-Ramos, Virginia
    Witcombe, David
    Soma, Koshika
    Zhang, Richard
    Thirunavukkarasu, Krishan
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 (03) : 115 - 126
  • [42] Conventional disease-modifying antirheumatic drugs in early arthritis
    Sokka, T
    Hannonen, P
    Möttönen, T
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2005, 31 (04) : 729 - +
  • [43] Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis
    Feely, Michael G.
    O'Dell, James R.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (03) : 316 - 320
  • [44] Survival of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
    Rosales Rosado, Zulema
    Leon, Leticia
    Freites Nunez, Dalifer
    Font Urgelles, Judit
    Leon Cardenas, Cynthia Milagros
    Vadillo Font, Cristina
    Rodriguez Rodriguez, Luis
    Jover Jover, Juan A.
    Abasolo Alcazar, Lydia
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [45] Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs
    Sizova, Lyudmila
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (02) : 173 - 178
  • [46] Disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis: Medical education
    Top, Cihan
    Terekeci, Hakan
    [J]. TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2008, 28 (03): : 387 - 398
  • [47] Etanercept in combination with conventional disease-modifying antirheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis patients intolerant to methotrexate
    Koyama, Yoshinobu
    Shiraishi, Hirokazu
    Ohta, Toshiyuki
    Uchino, Ayumi
    [J]. MODERN RHEUMATOLOGY, 2012, 22 (01) : 100 - 108
  • [48] Guidelines for the Use of Conventional and Newer Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis
    Diaz-Borjon, Alejandro
    [J]. DRUGS & AGING, 2009, 26 (04) : 273 - 293
  • [49] Guidelines for the Use of Conventional and Newer Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis
    Alejandro Díaz-Borjón
    [J]. Drugs & Aging, 2009, 26 : 273 - 293
  • [50] Prevalence of Anemia Among Rheumatoid Arthritis Patients Treated with Conventional Disease-Modifying Antirheumatic Drugs
    Kay, Jonathan
    Rancourt, Joshua
    Bradley, John D.
    Arora, Vipin K.
    Zhong, Jinglin
    Dickson, Christina
    Muram, David
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345